Botanical species · safety record

Desmodium styracifolium

The EFSA Compendium of Botanicals holds 10 constituent measurements for Desmodium styracifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Desmodium styracifolium (Osbeck) Merr.

10Constituent measurements

0Safety records

6Cited sources

21Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 21 licensed products naming Desmodium styracifolium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aerial parts
Dried aerial parts
Herb
Herb top
Herba
Stem and leaf

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Aerial part of plants	Solvent extraction	0.028 Percent	Unspecified	Resolve DOI
Formononetin	Unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Isoflavones	Unspecified	—	—	—	Resolve DOI
Desmodilactone	Aerial part of plants	—	—	Element spectroscopy	No resolvable identifier
Desmodimine	Aerial part of plants	—	—	Element spectroscopy	No resolvable identifier
Genistin	Unspecified	—	≤ 1.57 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Genistin	Unspecified	—	≥ 1.51 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Isoquercitrin	Unspecified	—	≤ 2.03 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Isoquercitrin	Unspecified	—	≥ 1.82 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Pentacyclic triterpene saponins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Guo, Panpan., Yan, Wenying., Han, Qingjie., Wang, Chunying., Zhang, Zijian. Simultaneous quantification of 25 active constituents in the total flavonoids extract from Herba Desmodii Styracifolii by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Journal of separation science, 2015, p. 1156-1163.
Su, Wen., Liu, Qi., Yang, Qing., Yu, Jingang., Chen, Xiaoqing. Separation and purification of four compounds from Desmodium styracifolium using off-line two-dimensional high-speed counter-current chromatography. JOURNAL OF SEPARATION SCIENCE, 2013, vol. 36, no. 20, p. 3338-3344. DOI
Aoshima, Taku., Kuroda, Minpei., Mimaki, Yoshihiro. Triterpene glycosides from the whole plants of Desmodium styracifolium. Natural Medicines (Tokyo, Japan), 2005.
Zhao, Ming., Duan, Jin-Ao., Che, Chun-Tao. Isoflavanones and their O-glycosides from Desmodium styracifolium. Phytochemistry, 2007, vol. 68, no. 10, p. 1471-1479. DOI
Yang, Z., Zhang, D., Ren, J., Yang, M., Li, S. Acetylcholinesterase inhibitory activity of the total alkaloid from traditional Chinese herbal medicine for treating Alzheimer's disease. Medicinal chemistry research, 2012, vol. 21, no. 6, p. 734-738. DOI
Yang, J S., Su, Y L., Wang, Y L. Studies on the chemical constituents of Desmodium styracifolium (Osbeck) Merr . . Yao xue xue bao = acta pharmaceutica sinica, 1993, vol. 28, no. 3, p. 197-201.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature